DexCom Inc (DXCM)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	4,425,900	4,698,400	5,002,900	3,767,400	3,668,800	3,398,500	3,808,700	3,746,600	3,684,400	3,656,200	3,474,200	3,445,100	3,424,800	3,237,100	3,033,000	1,995,700	1,969,400	1,815,700	1,744,200	1,690,800
Total current liabilities	US$ in thousands	1,556,000	1,678,600	2,069,700	1,865,000	1,839,300	900,500	807,000	711,400	720,800	734,900	600,700	604,100	614,100	506,400	400,100	342,800	360,200	322,400	288,200	235,400
Current ratio		2.84	2.80	2.42	2.02	1.99	3.77	4.72	5.27	5.11	4.98	5.78	5.70	5.58	6.39	7.58	5.82	5.47	5.63	6.05	7.18

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $4,425,900K ÷ $1,556,000K
= 2.84

The current ratio of Dexcom Inc has shown fluctuations over the past eight quarters, ranging from a low of 1.99 in Q4 2022 to a high of 5.27 in Q1 2022. The current ratio measures the company's ability to meet its short-term obligations with its current assets.

In recent quarters, Dexcom Inc has maintained a relatively healthy current ratio, indicating a strong ability to cover its short-term liabilities with its current assets. The current ratio has generally been above 2, which is considered a good benchmark for most industries.

However, there was a decline in the current ratio from Q2 2023 to Q4 2023, which may raise concerns about the company's liquidity position in the short term. It is important for investors and stakeholders to monitor the trend in the current ratio over time to assess Dexcom Inc's ability to manage its short-term financial obligations effectively.